Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?
Authors
Keywords
-
Journal
Vaccines
Volume 7, Issue 4, Pages 179
Publisher
MDPI AG
Online
2019-11-09
DOI
10.3390/vaccines7040179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
- (2019) Feng Long et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Haemagogus leucocelaenus and Haemagogus janthinomys are the primary vectors in the major yellow fever outbreak in Brazil, 2016–2018
- (2019) Filipe Vieira Santos de Abreu et al. Emerging Microbes & Infections
- Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
- (2019) Caroline S. de Freitas et al. PLoS Neglected Tropical Diseases
- Emergence and re-emergence of mosquito-borne arboviruses
- (2019) Yan-Jang S Huang et al. Current Opinion in Virology
- POLICI: A web application for visualising and extracting yellow fever vaccination coverage in Africa
- (2019) Arran Hamlet et al. VACCINE
- Yellow Fever and Orthotopic Liver Transplantation: new insights from the autopsy room for an old but reemerging disease
- (2019) Amaro Nunes Duarte‐Neto et al. HISTOPATHOLOGY
- Fractional-dose yellow fever vaccination: an expert review
- (2019) Anna H E Roukens et al. JOURNAL OF TRAVEL MEDICINE
- Predictors of mortality in patients with yellow fever: an observational cohort study
- (2019) Esper G Kallas et al. LANCET INFECTIOUS DISEASES
- Lipase and factor V (but not viral load) are prognostic factors for the evolution of severe yellow fever cases
- (2019) Luciana Vilas Boas Casadio et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture
- (2019) Tânia P. Pato et al. VACCINE
- Distinct YFV Lineages Co-circulated in the Central-Western and Southeastern Brazilian Regions From 2015 to 2018
- (2019) Edson Delatorre et al. Frontiers in Microbiology
- Detection of Yellow Fever Virus in Sylvatic Mosquitoes during Disease Outbreaks of 2017–2018 in Minas Gerais State, Brazil
- (2019) Guilherme Garcia Pinheiro et al. Insects
- Nucleoside Analogs with Antiviral Activity Against Yellow Fever Virus
- (2019) Keivan Zandi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines
- (2019) Nicholas Hernandez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Outbreak analytics: a developing data science for informing the response to emerging pathogens
- (2019) Jonathan A. Polonsky et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Human Schwann cells are susceptible to infection with Zika and yellow fever viruses, but not dengue virus
- (2019) Gaurav Dhiman et al. Scientific Reports
- Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
- (2019) Ismael Artur da Costa-Rocha et al. Frontiers in Immunology
- Mosquito and primate ecology predict human risk of yellow fever virus spillover in Brazil
- (2019) Marissa L. Childs et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children
- (2019) Ana Carolina Campi-Azevedo et al. Frontiers in Immunology
- Epizootic Outbreak of Yellow Fever Virus and Risk for Human Disease in Salvador, Brazil
- (2018) Igor Adolfo Dexheimer Paploski et al. ANNALS OF INTERNAL MEDICINE
- International travel between global urban centres vulnerable to yellow fever transmission
- (2018) Shannon E Brent et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Increased risk of yellow fever infections among unvaccinated European travellers due to ongoing outbreak in Brazil, July 2017 to March 2018
- (2018) Céline M Gossner et al. Eurosurveillance
- Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak — Preliminary Report
- (2018) Steve Ahuka-Mundeke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
- (2018) Yee Hwa Wong et al. Scientific Reports
- Aedes Mosquitoes and Aedes-Borne Arboviruses in Africa: Current and Future Threats
- (2018) David Weetman et al. International Journal of Environmental Research and Public Health
- The seasonal influence of climate and environment on yellow fever transmission across Africa
- (2018) Arran Hamlet et al. PLoS Neglected Tropical Diseases
- Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis
- (2018) Freya M Shearer et al. Lancet Global Health
- Fatal Yellow Fever in Travelers to Brazil, 2018
- (2018) Davidson H. Hamer et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation
- (2018) Cristina Possas et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Spatio-temporal spillover risk of yellow fever in Brazil
- (2018) RajReni B. Kaul et al. Parasites & Vectors
- The reemergence of yellow fever
- (2018) Alan D. T. Barrett SCIENCE
- Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model
- (2018) Justin G. Julander et al. Frontiers in Immunology
- Outbreak of yellow fever in central and southwestern Uganda, February–may 2016
- (2018) Leocadia Kwagonza et al. BMC INFECTIOUS DISEASES
- Reconstruction and prediction of viral disease epidemics
- (2018) M. U. G. Kraemer et al. EPIDEMIOLOGY AND INFECTION
- Urban yellow fever outbreak—Democratic Republic of the Congo, 2016: Towards more rapid case detection
- (2018) Brecht Ingelbeen et al. PLoS Neglected Tropical Diseases
- Integrated Aedes management for the control of Aedes-borne diseases
- (2018) David Roiz et al. PLoS Neglected Tropical Diseases
- International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017
- (2017) Ilaria Dorigatti et al. Eurosurveillance
- Detection of yellow fever virus genomes from four imported cases in China
- (2017) Shujuan Cui et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Vaccination Challenges in Confronting the Resurgent Threat From Yellow Fever
- (2017) Lin H. Chen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study
- (2017) Moritz U G Kraemer et al. LANCET INFECTIOUS DISEASES
- Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis
- (2017) Freya M Shearer et al. LANCET INFECTIOUS DISEASES
- Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
- (2017) Karina Takesaki Miyaji et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- Yellow fever from Angola and Congo: a storm gathers
- (2017) Qanta A Ahmed et al. TROPICAL DOCTOR
- WHO position on the use of fractional doses – June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper – June 2013
- (2017) World Health Organization VACCINE
- Geographic patterns and environmental factors associated with human yellow fever presence in the Americas
- (2017) Patricia Najera Hamrick et al. PLoS Neglected Tropical Diseases
- Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine
- (2017) Mark D. Gershman et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Addressing a Yellow Fever Vaccine Shortage — United States, 2016–2017
- (2017) Mark D. Gershman et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Questions regarding the safety and duration of immunity following live yellow fever vaccination
- (2016) Ian J. Amanna et al. Expert Review of Vaccines
- Adverse event reports following yellow fever vaccination, 2007–13
- (2016) Nicole P. Lindsey et al. JOURNAL OF TRAVEL MEDICINE
- A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein
- (2016) Fang Guo et al. JOURNAL OF VIROLOGY
- Fractional dosing of yellow fever vaccine to extend supply: a modelling study
- (2016) Joseph T Wu et al. LANCET
- Yellow Fever in Angola and Beyond — The Problem of Vaccine Supply and Demand
- (2016) Alan D.T. Barrett NEW ENGLAND JOURNAL OF MEDICINE
- Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis
- (2016) Leigh R. Bowman et al. PLoS Neglected Tropical Diseases
- The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells
- (2016) Alan M. Watson et al. PLoS Pathogens
- Yellow fever
- (2015) Thomas P. Monath et al. JOURNAL OF CLINICAL VIROLOGY
- Evidence-based vector control? Improving the quality of vector control trials
- (2015) Anne L. Wilson et al. TRENDS IN PARASITOLOGY
- An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
- (2015) Renata C. Pereira et al. VACCINE
- BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model
- (2014) Justin G. Julander et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
- (2014) Travis K. Warren et al. NATURE
- The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases
- (2014) Michael A. Johansson et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD)
- (2014) Stephen J. Seligman VACCINE
- Human Genetic Variation and Yellow Fever Mortality during 19th Century U.S. Epidemics
- (2014) L. E. Blake et al. mBio
- Yellow Fever in Africa: Estimating the Burden of Disease and Impact of Mass Vaccination from Outbreak and Serological Data
- (2014) Tini Garske et al. PLOS MEDICINE
- Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years
- (2013) Eduardo Gotuzzo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- 3′,5′Di-O-trityluridine inhibits in vitro flavivirus replication
- (2013) Tine De Burghgraeve et al. ANTIVIRAL RESEARCH
- Dynamic Viral Dissemination in Mice Infected with Yellow Fever Virus Strain 17D
- (2013) A. K. Erickson et al. JOURNAL OF VIROLOGY
- Yellow fever epizootics in non-human primates, São Paulo state, Brazil, 2008-2009
- (2013) Eduardo Stramandinoli Moreno et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes
- (2013) David W.C. Beasley et al. VIRUS RESEARCH
- Review of the risks and benefits of yellow fever vaccination including some new analyses
- (2012) Thomas P Monath Expert Review of Vaccines
- Epidemiological and laboratory characterization of a yellow fever outbreak in northern Uganda, October 2010–January 2011
- (2012) Joseph F. Wamala et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Development of a new hydrogen peroxide–based vaccine platform
- (2012) Ian J Amanna et al. NATURE MEDICINE
- Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
- (2012) Mark D. Gershman et al. VACCINE
- Why dengue and yellow fever coexist in some areas of the world and not in others?
- (2011) Marcos Amaku et al. BIOSYSTEMS
- Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk
- (2011) S. Kuhn et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Infant meningoencephalitis probably caused by yellow fever vaccine virus transmitted via breastmilk
- (2011) Cristiane Traiber et al. Jornal de Pediatria
- An Inactivated Cell-Culture Vaccine against Yellow Fever
- (2011) Thomas P. Monath et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein
- (2011) Yong-Qiang Deng et al. PLoS One
- Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort Study
- (2011) Anna H. Roukens et al. PLoS One
- Incubation Periods of Yellow Fever Virus
- (2010) Michael A. Johansson et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Is it time for a new yellow fever vaccine?
- (2010) Edward B. Hayes VACCINE
- WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009
- (2010) Morag Ferguson et al. VACCINE
- Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity
- (2010) Thomas P. Monath et al. VACCINE
- Yellow fever in Brazil: thoughts and hypotheses on the emergence in previously free areas
- (2010) Pedro Fernando da Costa Vasconcelos REVISTA DE SAUDE PUBLICA
- Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus
- (2009) Shuliu Zhang et al. JOURNAL OF INFECTIOUS DISEASES
- Production of yellow fever virus in microcarrier-based Vero cell cultures
- (2009) Marta Cristina O. Souza et al. VACCINE
- A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection
- (2009) Kathryn C. Meier et al. PLoS Pathogens
- Pressure-inactivated yellow fever 17DD virus: Implications for vaccine development
- (2008) Luciane P. Gaspar et al. JOURNAL OF VIROLOGICAL METHODS
- Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority Trial
- (2008) Anna H. Roukens et al. PLoS One
- Adverse event reports following yellow fever vaccination
- (2008) Nicole P. Lindsey et al. VACCINE
- Treatment of yellow fever
- (2007) Thomas P. Monath ANTIVIRAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now